US firm set to snap up Woodford's biotech holdings for $300m - reports

Acacia Research Corporation in talks with Link Fund Solutions

David Brenchley
clock
Neil Woodford has also tabled an offer for the portfolio
Image:

Neil Woodford has also tabled an offer for the portfolio

US-based Acacia Research Corporation is set to acquire a portfolio of biotech holdings owned by Woodford Investment Management for $300m, according to reports.

The portfolio, which comprises assets in the stricken LF Equity Income fund (EIF), includes the likes of Theravance Biopharma, Oxford Nanopore and Rutherford Cancer Centres, according to Sky News. The...

To continue reading this article...

Join Investment week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space

  • Get ahead of regulatory and technological changes affecting fund management

  • Important and breaking news stories selected by the editors delivered straight to your inbox each day

  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts

  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Funds

Threadneedle merges UK funds but AoV shows receiving fund still only rated moderate

Threadneedle merges UK funds but AoV shows receiving fund still only rated moderate

UK fund is £1.8bn

clock 25 November 2021 • 1 min read
Horizon by Embark CEO Thomas Rostron.

Navigating the fast-growing volatility managed sector

PA webinar in association with Horizon

Brian Gorman
clock 25 November 2021 • 3 min read
Vanguard to realign Global Balanced portfolio with sustainability criteria

Vanguard to align Global Balanced portfolio with sustainability criteria

Rebranding in December

clock 25 November 2021 • 1 min read